Correlation Between Contineum Therapeutics, and Humacyte
Can any of the company-specific risk be diversified away by investing in both Contineum Therapeutics, and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Contineum Therapeutics, and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Contineum Therapeutics, Class and Humacyte, you can compare the effects of market volatilities on Contineum Therapeutics, and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Contineum Therapeutics, with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Contineum Therapeutics, and Humacyte.
Diversification Opportunities for Contineum Therapeutics, and Humacyte
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Contineum and Humacyte is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Contineum Therapeutics, Class and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Contineum Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Contineum Therapeutics, Class are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Contineum Therapeutics, i.e., Contineum Therapeutics, and Humacyte go up and down completely randomly.
Pair Corralation between Contineum Therapeutics, and Humacyte
Given the investment horizon of 90 days Contineum Therapeutics, Class is expected to generate 0.6 times more return on investment than Humacyte. However, Contineum Therapeutics, Class is 1.66 times less risky than Humacyte. It trades about 0.22 of its potential returns per unit of risk. Humacyte is currently generating about -0.02 per unit of risk. If you would invest 600.00 in Contineum Therapeutics, Class on August 5, 2025 and sell it today you would earn a total of 501.00 from holding Contineum Therapeutics, Class or generate 83.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 98.46% |
| Values | Daily Returns |
Contineum Therapeutics, Class vs. Humacyte
Performance |
| Timeline |
| Contineum Therapeutics, |
| Humacyte |
Contineum Therapeutics, and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Contineum Therapeutics, and Humacyte
The main advantage of trading using opposite Contineum Therapeutics, and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Contineum Therapeutics, position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| Contineum Therapeutics, vs. Aldeyra | Contineum Therapeutics, vs. Vanda Pharmaceuticals | Contineum Therapeutics, vs. Annexon | Contineum Therapeutics, vs. Galectin Therapeutics |
| Humacyte vs. Silence Therapeutics PLC | Humacyte vs. Lexeo Therapeutics, Common | Humacyte vs. Voyager Therapeutics | Humacyte vs. Omeros |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |